You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HIGHLIGHTS

EVENTS

Kedrion Biopharma celebrates World Hemophilia Day 2018

Support for patients with coagulation disorders worldwide is confirmed

read more 

EVENTS

50-Year Anniversary of a Maternal Health Breakthrough

Kedrion Biopharma supports session on Anti-D achievements and challenges at FIGO Congress in Dubai

read more 

CORPORATE

Kedrion Biopharma runner up at the Premio Equita for the bond issued in July 2017

The prize is awarded to the companies that made the best use of the capital markets

read more 
  1. CORPORATE - 17-06-2016

    Kedrion Biopharma consolidates presence on Russian market

    Joint venture with Nacimbio of RosTECH group for a technology transfer to Kirov plant

    read more 
  2. CORPORATE - 26-05-2016

    SIPPET study results published in the “New England Journal of Medicine”

    This investigator-initiated clinical study involved 42 hemophilia treatment centers from all over the world

    read more 
  3. CORPORATE - 06-05-2016

    Kedrion Biopharma for Mother's Day

    We are committed to helping eliminate Rh disease worldwide by supporting initiatives like CURhE

    read more 
  4. EVENTS - 17-04-2016

    Kedrion initiatives for World Hemophilia Day 2016

    The goal is to improve access to treatments for people suffering from hemorrhagic conditions

    read more 

Pages

For more information please contact: pressoffice@kedrion.com